Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model - sprookjes - yvandenbroek - TriplyDB

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

http://www.wikidata.org/entity/Q28396881

about

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides Soluble epoxide hydrolase: gene structure, expression and deletion Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats Soluble epoxide hydrolase in atherosclerosis Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.Rationally designed multitarget agents against inflammation and pain.Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.Role of epoxide hydrolases in lipid metabolism Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.Metabonomics-based omics study and atherosclerosis.EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.Vascular pharmacology of epoxyeicosatrienoic acids Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice.Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie Profiling the regulatory lipids: another systemic way to unveil the biological mystery.

P2860

Q23913301-FCE1F4C9-0199-48B5-A534-FEA4C3E61A91 Q24616753-112EC644-0F2E-4C8D-896A-194055E191A9 Q24618018-444CB9CD-39CF-4304-BFAF-C1930BD33848 Q24628660-BE1E3D65-28EB-4B52-AE4A-CE117B5A2E3D Q27678172-DC46CCB2-A025-47A9-92C8-15B64E7F1E84 Q28291292-4BFD1BA4-A924-4B1E-9118-1F662B453788 Q28304230-DC9FA0DD-831D-449B-9777-E8B0DB12C7CE Q28385015-160432FB-19A1-4BE1-8D39-71761F69049B Q28386328-E219EB3B-5C4D-42A1-AA54-29C41F3BD362 Q28387540-68B8AF1D-EA71-4291-9102-243D7A4AC412 Q28389024-1E354572-979C-414A-9FA3-EF0AACDE2FBD Q28391172-4D7879ED-C85F-4A44-B1AA-6E3D49DEE973 Q28392609-C3D8DD4A-7F73-4C62-B2A6-855F7657F692 Q28395004-DF176603-0766-4DFD-9773-5F48B16A3FF4 Q28395478-3323F122-6D95-407B-BBD8-B82D560E9150 Q28551334-2FA54BF4-2592-4EC0-8404-ABC2BA29CE25 Q33652488-DA979C7A-7523-4928-A891-B5C5737D3566 Q33882374-3674E72E-DA4F-4D25-BEA3-4F1FEE580C80 Q33960685-F4952FD7-7F24-4809-8F63-88D4F8B1E336 Q34165559-82C5A2F0-6D6A-4B4F-836C-D866AB938940 Q34283241-FB3233A3-9E1D-4B52-BA79-32EE0AC8633B Q34783515-E9D197E0-44AC-43B7-95E6-38FD713B0DF7 Q35069446-3A2AEC8F-2592-4AF6-BF6C-6E4C647A9292 Q35195538-546216E2-6EDB-4FBC-8A7B-AE6075C9E280 Q35196023-48EDDE29-4098-405D-B476-0A528BEBFD49 Q35207683-F87073B6-EE8C-409F-8B6E-E5339BBA2CBE Q35568736-44AB5637-E0CF-47BC-9ADE-3106C2E57B40 Q35649907-4934B228-9C57-4BB0-9055-6A3819D184CD Q36027183-2CA67304-E50D-462F-BD26-7171474FE497 Q36094369-BDF8C442-7FDF-481D-8DFE-24C4C49418E7 Q36112019-DE6CA7CF-C4A1-4D26-A362-5591A333DB9F Q36545303-AA52B05D-B058-4AEA-B32B-46511B6981A0 Q36642542-6DFFA57A-C827-4B93-A848-E417B222E8DE Q36658386-9E0CD1CB-6E71-4DDC-BA0B-4520C04A76A2 Q36747783-7C946E45-EB2B-4FA6-A8EB-26197CD7EEEE Q36835930-263A57B5-01AF-46C4-955A-A4103560583B Q36877234-87C3F5B8-5975-4D65-A126-333C84636695 Q37170684-ED89831E-25E4-41D4-8C69-838B4949E3CE Q37250368-AAC49798-B81F-4ED5-9F37-7F3A72454E94 Q37871285-545372B7-1C65-4427-81CD-A0F19D2AB8E7

P2860

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

http://www.wikidata.org/entity/Q28396881

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@ast

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@en

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@nl

type

label

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@ast

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@en

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@nl

prefLabel

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@ast

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@en

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@nl

P1433

Q28396881-71CC0F74-F31F-4522-AA6B-574AA50A63E4

P1476

Q28396881-31A82282-6E38-4D12-9516-6AE8DB2DA422

P2093

Q28396881-1BB928E2-9BC9-43FA-9EB1-849E76804E9B

Q28396881-23E4C3B4-4A8A-4DE6-87D7-BCB997A95F53

Q28396881-40E52372-AC4E-40B8-8A73-290A6107F788

Q28396881-49ABC283-2215-4B85-812E-E6B0300D71EC

Q28396881-6C62C550-B8C8-4858-9E40-36EA88C4A9F7

P2860

Q28396881-041836AE-D1F4-451A-B11B-B1FD711CC4DA

Q28396881-06BC0ED1-ED22-4BEA-9779-63D40543799F

Q28396881-07FC2765-8E41-4C9F-AC67-AE212FBF0850

Q28396881-0CE67761-6684-401D-8D2C-73A84DA4793F

Q28396881-0E68560D-764C-47DE-898F-0B87143A0296

Q28396881-0FC4EBFA-27E2-47D5-993C-FB1BBD8EB146

Q28396881-1BDB225C-181D-4737-8D90-BBB69C75B9D6

Q28396881-1DB8BF69-57A5-4A48-B54F-9994C0C653B4

Q28396881-22495F4C-C4FA-4DD1-A318-6F213049A43A

Q28396881-253EF260-C74A-4F66-B919-00B5A58C1366

P304

Q28396881-5E3A2C7D-E984-4B42-88B2-CD6F2DCB0A13

P31

Q28396881-1294419B-9051-49D9-8BFA-B56BA77A3C72

P3181

Q28396881-98CBB9A2-98A0-4020-B813-F7F1CA2F6C12

P356

Q28396881-3342A391-7C73-4AB0-97AB-CD77F236E147

P407

Q28396881-58227FBC-816B-4AA6-BC23-386CA34655B2

P433

Q28396881-6A148512-4420-4195-B0BD-67A8F8F2BFB2

P478

Q28396881-9F3A98D3-0E5B-455D-8EA1-5EA8E11B6D2C

P50

Q28396881-36075751-4F49-47DA-983F-4F03BC591C23

Q28396881-AB070007-00BA-48A8-B75B-3779B13A5864

Q28396881-F5761C8E-D0E0-4A7A-918D-2B8F8427EFF7

P577

Q28396881-A68BCB35-B938-43D4-AF39-73569532DB47

P5875

Q28396881-6ED1FE79-7876-471A-B435-B28585D99351

P698

Q28396881-BD6440A0-B645-4320-95CA-318D2EDEF4C9

P921

Q28396881-2740F3A3-4AC6-4B53-BC8F-CB98B6F5A2CB

Q28396881-477FF8F6-9ABA-483D-AE4E-CD2B28FD648A

P932

Q28396881-14DC92AF-5E7A-4972-8923-D49440EA921B

P3181

P356

J.BCP.2009.10.025

P1433

Biochemical Pharmacology

P1476

Inhibition of soluble epoxide ...... in inhibitor in a murine model

@en

P2093

Arzu Ulu

http://www.w3.org/2001/XMLSchema#string

Bruce D Hammock

http://www.w3.org/2001/XMLSchema#string

Hong Qiu

http://www.w3.org/2001/XMLSchema#string

Nipavan Chiamvimonvat

http://www.w3.org/2001/XMLSchema#string

Sung-Hee Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

Metabolomics--a new exciting field within the "omics" sciences.

Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain

Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation

P304

880-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2341989

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BCP.2009.10.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38073715

http://www.w3.org/2001/XMLSchema#string

P698

19896470

http://www.w3.org/2001/XMLSchema#string

P921

P932

3285377

http://www.w3.org/2001/XMLSchema#string